LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
07/28/2026
Back to search
Official data from USPTO
MULTICLONICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MULTICLONICS
ST13
US500000079272312Class
1, 5, 42
Filing
79272312
Registration
6337244
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
07/28/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
09/16/2019
Registration date
05/04/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/04/2021
Last transaction
07/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
NL
Examiner
FALK, JONATHAN ROBERT
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Merus B.V.
Merus N.V.
Representatives
Max Vern Amster, Rothstein & Ebenstein LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemical products used in industry and sciencemutivalent proteinsincluding antibodies used in industry and sciencein the fields of immuno-oncologyauto-immunehematological and other unmet medical needs
Class 5
Pharmaceutical and veterinary preparations prepared with mutivalent proteinsincluding antibodiesused in industry and sciencefor use in the fields of immuno-oncologytreating auto-immune disorders and hematological disorders
Class 42
Services of biochemists; services of bacteriologic and biochemical laboratoriesincluding advice in these aspects; drawing up of professional reports by scientistsengineersanalysts and laboratory assistants and techniciansfor industry and government servicein particular in the field of multivalent proteinsincluding antibodiesin the fields of immuno-oncologyauto-immunehematological and other unmet medical needs; scientific and industrial research in particular in the field of antibodies for use in immuno-oncologytreating autoimmune disordershematological disorders and other non-oncology unmet medical needs; research and development of new products for third partiesin particular in the field of antibodies for use in immuno-oncologytreating auto-immune disordershematological disorders and other non-oncology unmet medical needs
Publications
History of USPTO decisions and trademark events.
55 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/28/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/28/2026
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
05/28/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/28/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/28/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/28/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/28/2026
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
05/07/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/04/2026
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/19/2026
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/16/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/11/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/11/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/04/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/16/2021
FIMP
FINAL DISPOSITION PROCESSED
08/16/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/04/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/10/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
05/04/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/21/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/21/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/16/2021
PUBO
PUBLISHED FOR OPPOSITION
02/16/2021
GPNX
NOTIFICATION PROCESSED BY IB
02/14/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/27/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/27/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/27/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/08/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/08/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/08/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/09/2020
GNFR
FINAL REFUSAL E-MAILED
07/09/2020
CNFR
FINAL REFUSAL WRITTEN
07/09/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/16/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/16/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/16/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/16/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/16/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/16/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/16/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/16/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/16/2020
RFNT
REFUSAL PROCESSED BY IB
02/08/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/22/2020
RFRR
REFUSAL PROCESSED BY MPU
01/22/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/21/2019
CNRT
NON-FINAL ACTION WRITTEN
12/20/2019
DOCK
ASSIGNED TO EXAMINER
12/16/2019
MAFR
APPLICATION FILING RECEIPT MAILED
11/29/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/25/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/21/2019
Continuous trademark protection
Get notified about every new filing that threatens MULTICLONICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.